Corporations Canada has issued the following two publications in light of the COVID-19 outbreak:
- Corporations Canada extends annual return deadlines to September 30 for federal corporations during the COVID-19 outbreak – issued April 1, 2020
Here is the link.
Corporations Canada is extending the annual return filing periods for federally incorporated not-for-profit organization. Federally incorporated not-for-profit organizations whose anniversary date is between February 1 and June 30 now have until September 30, 2020 to file their annual return. Normally, corporations are required to file their annual return within 60 days of their anniversary date.
Even though Corporations Canada has extended the deadline to file annual returns, Miller Thomson LLP’s Social Impact Group will continue to reach out to our clients in the normal course to prepare and file annual returns.
- Annual meetings of federal corporations during the COVID-19 outbreak – updated March 26, 2020
Here is the link.
The publication outlines options for federal corporations to hold virtual or partially virtual meetings during the COVID-19 outbreak and outlines the parameters around electronic voting.
The publication also explains that organizations can delay the annual meeting by emailing Corporations Canada at least 30 business days before sending the notice calling the meeting. Here you will find Corporations Canada’s policy on extending annual meetings and the information you must provide in order to apply.
Please refer to the Social Impact Group’s article “The COVID-19 Pandemic: Key considerations for charity and non-profit governance”, issued March 20, 2020 for more information on this subject. Here is a link.
Miller Thomson LLP’s Social Impact Group would be pleased to answer any questions or assist with these issues. Please do not hesitate to contact us.
Miller Thomson is closely monitoring the situation around the COVID-19 pandemic to ensure that we provide our clients with the appropriate support in this rapidly changing environment. For additional information, please see our COVID-19 resources page.